Xencor Inc — Director's Dealing 2013

Dec 2, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2013-12-02

Reporting Person: SARAN ATUL (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A-1 Preferred Stock	$		Common Stock (1319522)		Indirect

Footnotes

F1: Every 3.1 shares of the Series A-1 Preferred Stock is convertible into 1 share of the Issuer's Common Stock at any time, at the holder's election, and has no expiration date.

F2: Held of record by MedImmune Ventures, Inc. ("MedImmune"). The Reporting Person is the chairperson of the six-person investment committee of MedImmune. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.